Dr. Lal PathLabs has informed that a meeting of the Board of Directors is scheduled to be held on Wednesday, August 7, 2024 to consider and approve the Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30, 2024 and to consider recommending Interim Dividend, if any, on the Equity Shares of the Company for the Financial Year 2024-25. Further, in continuation to our letter dated June 26, 2024 and in line with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company is closed and shall re-open after 48 hours from the declaration of the aforesaid Financial Results.
The above information is a part of company’s filings submitted to BSE.